UPDATE: Due to the ongoing transition at the US Department of Health and Human Services and pause on speaking engagements by FDA representatives, we have postponed this session of “Fundamentals of Biotech Development: Biologics, Vaccines, Cells & Gene Therapy,” as PERI has several expert faculty who present at this course from the US Food and Drug Administration and HHS.

New Course Date: June 24-25, 2025

This course explores the historic and current environment of biologics and biosimilars, including how they are developed, regulated, and manufactured. The course explores a variety of biotherapeutic treatments, including vaccines, cell therapy, and gene therapy, as well as explores the future of non-small molecule therapies. Participants will gain a broad multidisciplinary understanding of the scientific, management and regulatory decision points in the development of new biologics and biotech products.

Course Prices:
Individual Course Registration: $1,375.00 USD
Early Individual Course Registration: $1,175.00 USD

Early Bird Registration ends Friday, May 10, 2025.

Please allow up to 24 hours to receive your official course registration confirmation.

** Special savings alert! Now through February 14, take advantage of our increased group rate discounts when you register two individuals for any upcoming open course – now save 25%! **